Topic 2 - Meso Compounds and Optical Activity

Stereochemical Exceptions and Meso Compounds

  • Stereogenic centers and molecular symmetry:

    • A molecule containing stereogenic centers is not guaranteed to be chiral; when the groups attached to the stereogenic centers are symmetrically distributed across the molecule, the molecule can be achiral and therefore optically inactive.

    • According to stereochemical configuration rules, a molecule with nn stereogenic centers can theoretically have up to 2n2^n possible stereoisomers. For a molecule with n=2n = 2 stereocenters, the theoretical maximum is 22=42^2 = 4 stereoisomers.

    • Symmetrical substitution reduces the actual number of stereoisomers from four to three due to the identity of certain stereoisomeric representations.

  • Stereoisomers of 2,3-dihydroxybutane-1,4-dioic acid2,3\text{-dihydroxybutane-}1,4\text{-dioic acid} (tartaric acid):

    • Tartaric acid contains a four-carbon chain with terminal carboxylic acid groups at carbons 11 and 44 (1,4-dioic acid1,4\text{-dioic acid}) and hydroxyl groups (−OH-\text{OH}) located at carbons 22 and 33.

    • Carbons 11 and 44 are achiral because they contain double bonds (C=O\text{C}=\text{O}), leaving carbons 22 and 33 as the two stereogenic centers.

    • Pair of true enantiomers:

    • The (2S,3S)(2S, 3S) configuration and the (2R,3R)(2R, 3R) configuration are non-superimposable mirror images of each other.

    • These two configurations are not interconvertible, represent distinct real chemical entities, and are genuine optically active enantiomers.

    • Predicted diastereomeric pair:

    • Inversion of a single center yields the predicted configurations (2R,3S)(2R, 3S) and (2S,3R)(2S, 3R).

    • Detailed spatial analysis demonstrates that the (2R,3S)(2R, 3S) and (2S,3R)(2S, 3R) structures are completely identical and superimposable.

    • Consequently, tartaric acid does not possess four stereoisomers, but only three.

  • Structural proof of identity in meso-tartaric acid:

    • Flipping along the central carbon-carbon (C−C\text{C}-\text{C}) axis:

    • Flipping the whole molecule along its central axis (rather than rotating around the bond) superimposes the two forms.

    • Upon flipping, the bottom −COOH-\text{COOH} group moves to the top position.

    • The hydrogen atom (−H-\text{H}) at the bottom reorients to the back, pointing downward.

    • The hydroxyl group (−OH-\text{OH}) moves to the front.

    • The top −COOH-\text{COOH} group rotates to the bottom.

    • The top −OH-\text{OH} group moves to the top, pointing away, while the top −H-\text{H} atom reorients to the top, pointing toward the viewer.

    • Because the flipped structure aligns point-for-point with the alternate configuration, the two are superimposable identical forms rather than non-superimposable mirror images.

    • Bond rotation demonstration:

    • Rotating the left half of the (2R,3S)(2R, 3S) molecule around the central C−C\text{C}-\text{C} single bond by 180∘180^\circ causes the −COOH-\text{COOH} group to point to the top, the −OH-\text{OH} group to project to the back, and the −H-\text{H} atom to project to the front.

    • Rotating the right half of the molecule around the bond by 180∘180^\circ reorients the substituents into the identical spatial layout of the other representation.

    • Nomenclature and properties of meso compounds:

    • Designating these structures as (2R,3S)(2R, 3S) and (2S,3R)(2S, 3R) is a formal mislabeling of separate isomers, as they are the exact same chemical substance.

    • The correct designation for this configuration is meso-tartaric acid.

    • A meso compound arises whenever a molecule with stereogenic centers contains an internal plane of symmetry that bisects the molecule.

    • Optical activity is internally canceled across the plane of symmetry, making meso compounds optically inactive (achiral).

Meso Forms in Cyclic Systems

  • Stereoisomerism in cyclopropane-1,2-dicarboxylic acid1,2\text{-dicarboxylic acid}:

    • Cyclic structures exhibit identical symmetry-enforced reductions in stereoisomer count.

    • trans-Isomers:

    • Comprise the (1S,2S)(1S, 2S) and (1R,2R)(1R, 2R) configurations, wherein the two carboxylic acid groups project on opposite sides (faces) of the cyclopropane ring.

    • These structures are non-superimposable mirror images regardless of molecular spatial rotation.

    • They constitute a legitimate pair of optically active enantiomers.

    • cis-Isomer:

    • Both carboxylic acid groups reside on the same face of the cyclopropane ring.

    • The cis structure features an internal plane of symmetry that bisects the cyclopropane ring between carbons 11 and 22 and passes through carbon 33.

    • Inverting the structure such that the two carboxylic acid groups point downward rather than upward yields the identical molecule via simple spatial reorientation.

    • As a result of this internal plane of symmetry, the cis isomer is a meso compound and lacks optical activity.

Principles and Instrumentation of Optical Activity

  • Definition and fundamental behavior:

    • Optical activity is the physical ability of a chiral compound to rotate the plane of plane-polarized light.

    • Enantiomers have opposite configurations at all stereogenic centers (whether a molecule possesses 11, 22, 33, or nn stereocenters).

    • From a chemical perspective in achiral environments, enantiomers are identical, but they interact with plane-polarized light in opposite manners.

  • Polarimeter components and measurement mechanism:

    • Light source:

    • Generates normal white light, which consists of electromagnetic waves oscillating randomly in all directional planes perpendicular to the line of propagation.

    • Polarizing filter:

    • Isolates a single orientation of the oscillating light waves to generate plane-polarized light (operating on the same principle as polarized sunglasses).

    • Monochromatic light standard:

    • Standard measurements utilize monochromatic light, specifically the D line of a sodium lamp at a wavelength of λ=589 nm\lambda = 589\,\text{nm}.

    • Sample holder:

    • A standardized sample tube of fixed path length containing the solution of the chiral compound.

    • Optical rotation detection:

    • When plane-polarized light travels through an optically active sample, the compound rotates the plane of polarization.

    • A rotatable analytical detector determines and reads out the degree of rotation, designated as α\alpha.

  • Determinants of observed rotation (α\alpha):

    • α\alpha is the experimentally observed angle of rotation recorded directly from the polarimeter.

    • The extent of α\alpha depends upon five parameters:

    • Path length (ll) of the sample tube (longer paths increase the degree of rotation).

    • Concentration (cc) of the chiral substance in solution.

    • Temperature of the system.

    • Solvent used to dissolve the analyte (e.g., ethanol, chloroform).

    • Incident wavelength of the light source.

Quantitative Characterization: Specific Optical Rotation

  • Conversion of observed rotation to specific rotation:

    • To eliminate the variables of cell length and solution concentration, the raw observed rotation (α\alpha) is converted into specific rotation ([α][\alpha]), an intrinsic physical constant unique to each chiral substance.

    • Specific rotation formula:     [α]=αl×c[\alpha] = \frac{\alpha}{l \times c}

    • Under standard conditions (20∘C20^\circ\text{C} and the sodium D line of 589 nm589\,\text{nm}), specific optical rotation is symbolized as [α]D20[\alpha]_D^{20}:     [α]D20=αl×c[\alpha]_D^{20} = \frac{\alpha}{l \times c}

  • Standardized measurement units:

    • Observed rotation (α\alpha) is expressed in degrees (∘^\circ).

    • Path length (ll) is defined in decimeters (dm\text{dm}), where 1 dm=10 cm1\,\text{dm} = 10\,\text{cm}.

    • Concentration (cc) is defined not as molarity, but as a mass concentration (density) in grams per milliliter (g/mL\text{g/mL} or g cm−3\text{g}\,\text{cm}^{-3}).

  • Optical properties of enantiomers and racemates:

    • Equal and opposite rotation:

    • Enantiomers rotate plane-polarized light by an identical absolute numerical value, but in opposite directions.

    • One enantiomer is dextrorotatory (rotates the plane to the right, denoted by a positive sign, ++).

    • The opposite enantiomer is levorotatory (rotates the plane to the left, denoted by a negative sign, −-).

    • Racemic mixture (racemate):

    • An equimolar (1:11:1) mixture of two opposing enantiomers.

    • The equal and opposite rotations cancel out completely, producing an optically inactive sample with a net rotation of zero (α=0∘\alpha = 0^\circ).

  • Independence of optical sign from stereochemical configuration:

    • It is impossible to predict the sign (++ or −-) or the magnitude of optical activity from the two-dimensional or three-dimensional structure or absolute configuration (RR or SS) of a molecule.

    • Optical rotation values and signs must be established through empirical polarimeter measurements.

    • The absolute configuration descriptors (RR and SS) are theoretical assignments based on the spatial arrangement and priority of groups around a chiral center; they do not correlate with optical rotation signs:

    • A minus sign (−-) does not signify an SS or RR configuration.

    • A plus sign (++) does not signify an RR or SS configuration.

    • If an S-enantiomerS\text{-enantiomer} is experimentally shown to be levorotatory (−-), its corresponding R-enantiomerR\text{-enantiomer} will be dextrorotatory (++) with equal magnitude, but which enantiomer rotates in which direction cannot be derived a priori.

Physical, Chemical, and Spectroscopic Properties of Stereoisomers

  • Properties of enantiomers:

    • Pure enantiomers share identical physical properties in achiral environments, including identical melting points and boiling points.

    • Spectroscopic properties, including nuclear magnetic resonance (NMR\text{NMR}) spectra and mass spectrometry (MS\text{MS}) fragmentation patterns, are identical between enantiomers and cannot be used to distinguish them.

    • Enantiomers differ only in their interaction with plane-polarized light (optical rotation sign) and their behavior in chiral environments (such as chiral biological receptors).

  • Properties of racemates versus pure enantiomers:

    • Racemates typically possess different physical properties—most notably melting points—compared to the pure enantiomers.

    • The presence of enantiomeric contamination within an otherwise pure enantiomeric sample alters the observed melting point due to differences in crystal lattice interactions.

  • Properties of diastereoisomers:

    • Diastereoisomers possess completely different physical and chemical properties.

    • For example, while the enantiomeric pair (+)-ephedrine(+)\text{-ephedrine} and (−)-ephedrine(-)\text{-ephedrine} share identical melting points and chemical reactivities, the diastereomeric pair (−)-ephedrine(-)\text{-ephedrine} and (−)-pseudoephedrine(-)\text{-pseudoephedrine} display entirely distinct melting points, solubilities, and chemical behaviors.

Biological and Pharmacological Activity of Enantiomers

  • Mechanism of stereoselective receptor binding:

    • Biological macromolecules (enzymes, receptors, transporters) are chiral environments, meaning enantiomers often exhibit disparate biological and pharmacological activities.

    • Achiral binding dominance:

    • If a drug molecule consists of an achiral core or tail that mediates the principal interactions with the receptor, the stereochemical orientation at an adjacent chiral center may have negligible effect on affinity or efficacy.

    • Under this scenario, both enantiomers exhibit identical or near-identical biological activity.

    • Chiral center binding dominance (Three-Point Interaction Model):

    • If the chiral center itself is directly involved in binding, the substituents (XX, YY, and ZZ) around the stereogenic center must interact with specific complementary binding pockets on the receptor.

    • In one enantiomer, substituents XX, YY, and ZZ align in perfect spatial complementarity with the receptor's binding sites.

    • In the opposite enantiomer, spatial inversion prevents simultaneous alignment of all three substituents; at least one critical binding interaction is lost.

    • This misalignment leads to marked differences in pharmacological potency, efficacy, or qualitative activity.

  • Potential biological activity profiles between enantiomeric pairs:

    • Only one enantiomer is biologically active, while the other is completely inactive.

    • Both enantiomers possess essentially identical biological activity.

    • Both enantiomers possess similar pharmacological activity, but one is quantitatively more active (higher potency).

    • The two enantiomers produce completely different pharmacological or toxicological responses.

  • Pharmacological Case Studies:

    • Ibuprofen:

    • Exists as two enantiomers: the R-isomerR\text{-isomer} and the S-isomerS\text{-isomer}.

    • At the direct enzymatic target level, the S-enantiomerS\text{-enantiomer} is the active anti-inflammatory agent, whereas the R-enantiomerR\text{-enantiomer} is inactive.

    • In clinical practice, ibuprofen is formulated and administered as a racemate because human metabolic pathways actively convert the inactive R-enantiomerR\text{-enantiomer} into the active S-enantiomerS\text{-enantiomer} in vivo.

    • Thalidomide:

    • The R-enantiomerR\text{-enantiomer} provides therapeutic sedative and antidepressant activities.

    • The S-enantiomerS\text{-enantiomer} is teratogenic; when administered to pregnant women, it caused severe congenital birth defects.

    • Hyoscyamine and Atropine:

    • Hyoscyamine is an anticholinergic drug whose therapeutic activity resides exclusively in the S-enantiomerS\text{-enantiomer}, while the R-enantiomerR\text{-enantiomer} is inactive.

    • Atropine is the clinically utilized drug form, consisting of a racemic (50:5050:50) mixture of the R-R\text{-} and S-enantiomersS\text{-enantiomers}.

    • Because the R-enantiomerR\text{-enantiomer} contributes no activity, atropine demonstrates exactly 50%50\% of the anticholinergic activity exhibited by an equivalent dose of pure S-hyoscyamineS\text{-hyoscyamine}.